BE901704A - Procede d'encapsulation, notamment de cellules, dans des membranes semi-permeables. - Google Patents

Procede d'encapsulation, notamment de cellules, dans des membranes semi-permeables.

Info

Publication number
BE901704A
BE901704A BE0/214493A BE214493A BE901704A BE 901704 A BE901704 A BE 901704A BE 0/214493 A BE0/214493 A BE 0/214493A BE 214493 A BE214493 A BE 214493A BE 901704 A BE901704 A BE 901704A
Authority
BE
Belgium
Prior art keywords
semi
gelled masses
encapsulation process
permeable membranes
aqueous solution
Prior art date
Application number
BE0/214493A
Other languages
English (en)
Inventor
W G Tsang
A W S Shyr
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of BE901704A publication Critical patent/BE901704A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

Procédé qui comprend la gélification d'un polymère polyanionique hydrosoluble contenant une matière d'ame dans une solution aqueuse contenant des cations polyvalents, afin que des masses gélifiées séparées se forment, puis l'expansion de ces masses gélifiées dans une solution aqueuse qui retire une partie des cations polyvalents et assure une hydratation des masses gélifiées, et la formation d'une membrane autour des masses gélifiées, par réaction entre des groupes anioniques du polymère polyanionique et des groupes cationiques d'un polymère polycationique dont la masse moléculaire dépasse 3000 daltons.
BE0/214493A 1984-02-13 1985-02-11 Procede d'encapsulation, notamment de cellules, dans des membranes semi-permeables. BE901704A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/579,494 US4663286A (en) 1984-02-13 1984-02-13 Encapsulation of materials

Publications (1)

Publication Number Publication Date
BE901704A true BE901704A (fr) 1985-05-29

Family

ID=24317126

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214493A BE901704A (fr) 1984-02-13 1985-02-11 Procede d'encapsulation, notamment de cellules, dans des membranes semi-permeables.

Country Status (14)

Country Link
US (1) US4663286A (fr)
JP (1) JPS60190229A (fr)
AU (1) AU572609B2 (fr)
BE (1) BE901704A (fr)
CA (1) CA1238273A (fr)
CH (1) CH665137A5 (fr)
DE (1) DE3504724C2 (fr)
DK (1) DK65285A (fr)
FR (1) FR2559502B1 (fr)
GB (1) GB2153780B (fr)
IT (1) IT1184885B (fr)
NL (1) NL8500352A (fr)
NO (1) NO850535L (fr)
SE (1) SE8500623L (fr)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127989A3 (fr) * 1983-06-01 1986-03-26 Connaught Laboratories Limited Micro-encapsulation de tissu vivant et de cellules
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
SE8405105L (sv) * 1984-05-24 1985-11-25 Damon Biotech Inc Sett for screening av celler
US4871671A (en) * 1985-04-29 1989-10-03 Minnesota Mining And Manufacturing Company Immobilization of biological cells in polytetrafluoroethylene matrix
IL79052A0 (en) * 1986-06-06 1986-11-30 Univ Ramot Device and process for production of alginate-shell beads containing biologically active material
JPS6434436A (en) * 1987-07-28 1989-02-03 Sanyo Chemical Ind Ltd Gel cellular beads and manufacture thereof
US4923645A (en) * 1987-11-16 1990-05-08 Damon Biotech, Inc. Sustained release of encapsulated molecules
US5605835A (en) * 1988-05-23 1997-02-25 Regents Of The University Of Minnesota Bioreactor device with application as a bioartificial liver
US5389532A (en) * 1988-07-07 1995-02-14 Champagne Moet & Chandon Process of producing a dehydrated polysaccharide gel containing microorganisms for preparing fermented drinks
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
JPH04505701A (ja) * 1989-02-21 1992-10-08 バイオシス 虫生線虫をパッケージ化するための方法および媒体
DE3908997A1 (de) * 1989-03-18 1990-09-20 Huels Chemische Werke Ag Verfahren zur herstellung immobilisierter hefen fuer die sektgaerung
WO1991001720A1 (fr) * 1989-08-07 1991-02-21 Herman Wade Schlameus Composition et procede favorisant la cicatrisation de tissus durs
US5101814A (en) * 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5459054A (en) * 1989-12-05 1995-10-17 Neocrin Company Cells encapsulated in alginate containing a high content of a- l- guluronic acid
WO1991007951A1 (fr) * 1989-12-05 1991-06-13 Trancel Corporation Composition de revêtement a base d'alginate comprenant de l'acide guluronique homologue destinee a etre appliquee et implantee in vivo et procede d'utilisation
WO1991009119A1 (fr) * 1989-12-13 1991-06-27 Trancel Corporation Microcapsules d'alginate ameliorees et procedes pour leur fabrication et leur utilisation
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
DE59107006D1 (de) * 1990-04-25 1996-01-18 Hoechst Ag Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff.
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5380536A (en) 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
FR2673122B1 (fr) * 1991-02-25 1994-09-09 Moet & Chandon Gel ionotrope deficient en entite ionique de gelification, procede de preparation d'un tel gel et utilisation de celui-ci notamment dans un procede d'elaboration de vin effervescent.
CA2109085C (fr) * 1991-04-25 2003-03-11 Keith E. Dionne Vehicule implantable, biocompatible et immuno-isolateur pour l'administration de produits therapeutiques selectionnes
US5800829A (en) * 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
US5545423A (en) * 1991-11-25 1996-08-13 Vivorx, Inc. Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
AU687728B2 (en) * 1991-11-25 1998-03-05 Vivorx, Inc. Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
WO1994015589A1 (fr) * 1992-12-30 1994-07-21 Clover Consolidated, Limited Systemes de conditionnement de substances biologiquement actives dans des macrocapsules recuperables, biocompatibles et cytoprotectrices
US5170744A (en) * 1991-12-13 1992-12-15 Biosys Corporation Long-term storage of infective juvenile nematodes in pseudoplastic layers
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
KR100266912B1 (ko) * 1992-02-28 2000-12-01 파라비 레이 조직접촉물질이며 방출조절운반체인 광중합성 생분해성 하이드로겔
US5578442A (en) * 1992-03-23 1996-11-26 Vivorx, Inc. Graft copolymers of polycationic species and water-soluble polymers, and use therefor
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5643594A (en) * 1992-05-29 1997-07-01 The Regents Of The University Of California Spin encapsulation apparatus and method of use
EP0641196B1 (fr) * 1992-05-29 2001-08-22 Vivorx, Incorporated Microencapsulation de cellules
US5521079A (en) * 1994-01-24 1996-05-28 The Regents Of The University Of California Microcapsule generating system containing an air knife and method of encapsulating
US6001387A (en) * 1992-05-29 1999-12-14 The Reguents Of The University Of California Spin disk encapsulation apparatus and method of use
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
US5429821A (en) * 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
WO1993024076A1 (fr) * 1992-05-29 1993-12-09 The Regents Of The University Of California Transplant revetu et procede de fabrication correspondant
WO1994012161A1 (fr) * 1992-11-24 1994-06-09 Clover Consolidated, Limited Macrocapsules cytoprotectrices, biocompatibles et recuperables
DE4312970A1 (de) * 1993-04-21 1994-10-27 Juergen Dr Schrezenmeir Mikrokapsel sowie Verfahren und Vorrichtung zu ihrer Herstellung
DE69420024T2 (de) 1993-08-10 2000-02-24 W.L. Gore & Associates, Inc. Zelleinkapselungsvorrichtung
US5965149A (en) * 1993-08-13 1999-10-12 Thermo Trilogy Corporation Granular formulation of biological entities with improved storage stability
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
AU681240C (en) * 1994-01-13 2006-12-07 Rogosin Institute, The Macroencapsulated secretory cells
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US5514377A (en) * 1994-03-08 1996-05-07 The Regents Of The University Of California In situ dissolution of alginate coatings of biological tissue transplants
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
CA2214088A1 (fr) * 1995-03-03 1996-09-12 Metabolex Inc. Nouveau processus d'encapsulation par un polymere gelifiant
JP3265918B2 (ja) * 1995-06-15 2002-03-18 矢崎総業株式会社 乾燥したゲル被覆種子の復元方法
US6096344A (en) 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
AU6854696A (en) * 1995-09-22 1997-04-09 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
US7041634B2 (en) 1995-09-27 2006-05-09 Emory University Method of inhibiting immune system destruction of transplanted viable cells
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
EP1382346B1 (fr) * 1996-04-03 2007-09-26 The Rogosin Institute Milieu conditionné et produit biologique diffusible obtenu par incubation de cellules piégées
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6033887A (en) * 1997-05-05 2000-03-07 Champagne Moet & Chandon Dehydrated polysaccharide gel containing microorganisms, a sugar and a polyol for producing fermented drinks
GB2327074B (en) * 1997-07-07 2001-09-12 Norsk Hydro As Improvements in or relating to capsules
US6368612B1 (en) 1997-12-12 2002-04-09 Biohybrid Technologies Llc Devices for cloaking transplanted cells
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
WO1999047253A1 (fr) * 1998-03-19 1999-09-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Fabrication de particules et de coques creuses enduites multicouches par assemblage automatique de multicouches de nanocomposites sur des gabarits colloidaux decomposables
US7101575B2 (en) * 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE29924358U1 (de) * 1998-03-19 2003-01-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 80539 München Nano- und Mikrokapseln mit einer Polyelektrolythülle aus mehreren Polyelektrolytschichten
DE59914547D1 (de) * 1998-07-15 2007-12-20 Max Planck Gesellschaft Polyelektrolythüllen auf biologischen templaten
AU1623300A (en) * 1998-11-13 2000-06-05 Sensor Technologies, Inc. Monodisperse preparations useful with implanted devices
US6495161B1 (en) * 1999-03-09 2002-12-17 Vivorx, Inc. Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6645525B1 (en) 1999-06-23 2003-11-11 Sedum Laboratories, Inc. Ionically formulated biomolecule microcarriers
WO2001064329A1 (fr) * 2000-02-29 2001-09-07 Rainer Pommersheim Microcapsule s"utilisant notamment pour immobiliser des solides, des liquides organiques ou inorganiques et/ou des gaz
AU2001273234A1 (en) * 2000-07-05 2002-01-14 Islet Technology, Inc. Method and system for consistent and effective encapsulation of biological material
US6790455B2 (en) * 2001-09-14 2004-09-14 The Research Foundation At State University Of New York Cell delivery system comprising a fibrous matrix and cells
WO2004075855A2 (fr) 2003-02-26 2004-09-10 Biomed Solutions, Llc Procede de traitement in vivo de cibles biologiques specifiques dans un fluide corporel
US20050053586A1 (en) 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20050095174A1 (en) * 2003-10-31 2005-05-05 Wolf David E. Semipermeable sensors for detecting analyte
DE102004013637A1 (de) * 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
DE102004019241A1 (de) * 2004-04-16 2005-11-03 Cellmed Ag Injizierbare vernetzte und unvernetzte Alginate und ihre Verwendung in der Medizin und in der ästhetischen Chirurgie
EP1595534A1 (fr) * 2004-05-13 2005-11-16 Universiteit Utrecht Holding B.V. Gel composant des polymeres charges
EP1807506B1 (fr) * 2004-10-08 2013-04-17 Georgia Tech Research Corporation Microencapsulation de cellules dans des hydrogels a l'aide de potentiels electrostatiques
DE102004055729A1 (de) * 2004-11-18 2006-05-24 Cellmed Ag Herstellung von zwei-oder mehrschichtig aufgebauten Mikrokapseln
CA2602029C (fr) 2005-03-11 2014-07-15 Wake Forest University Health Sciences Vaisseaux sanguins realises par genie tissulaire
JP2007082485A (ja) * 2005-09-22 2007-04-05 Hitachi Plant Technologies Ltd 包括固定化担体、その製造方法、及び保管・輸送方法
US20090196854A1 (en) * 2008-02-04 2009-08-06 Kytos Biosystems S.A. Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
US9694055B2 (en) 2008-05-09 2017-07-04 Wake Forest University Health Sciences Renal tissue regeneration
US9205395B2 (en) * 2009-10-15 2015-12-08 Encapsys, Llc Encapsulation
JP6046644B2 (ja) 2011-03-04 2016-12-21 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ホルモン補充療法のためのカプセル化された細胞
JP2014509617A (ja) 2011-03-29 2014-04-21 ベタ−セル エンフェー 治療薬のカプセル化方法、およびその使用
KR20140039007A (ko) * 2011-06-29 2014-03-31 더 유니버시티 오브 아크론 캡슐화 및 고정 방법
US11096898B2 (en) 2018-11-16 2021-08-24 GH Care Inc. Alginate microcapsules for cell and molecular therapy that secrete bioactive immune molecules
US12584104B2 (en) 2019-03-29 2026-03-24 Wake Forest University Health Sciences Ovarian follicle cells and constructs for fertility treatment and hormone replacement therapy
WO2022145419A1 (fr) * 2020-12-28 2022-07-07 持田製薬株式会社 Structure multicouche utilisant de l'acide alginique chimiquement réticulé

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD36655A3 (fr) * 1964-06-12 1965-11-05
DE1917738B2 (de) * 1969-04-05 1980-06-26 Bayer Ag, 5090 Leverkusen Verfahren zum Einbetten bzw Umhüllen von festen oder flussigen Substanzen
GB1302275A (fr) * 1970-03-26 1973-01-04
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
NO158284C (no) * 1981-03-13 1988-08-17 Damon Biotech Inc Fremgangsmaate for selektiv oppbrytning av en permeabel membran.
US4439488A (en) * 1982-02-26 1984-03-27 The United States Of America As Represented By The Secretary Of Agriculture Encapsulation by entrapment within polyhydroxy polymer borates
US4582799A (en) * 1983-04-15 1986-04-15 Damon Biotech, Inc. Process for recovering nonsecreted substances produced by cells

Also Published As

Publication number Publication date
US4663286A (en) 1987-05-05
AU572609B2 (en) 1988-05-12
GB2153780A (en) 1985-08-29
SE8500623D0 (sv) 1985-02-12
CH665137A5 (de) 1988-04-29
IT1184885B (it) 1987-10-28
IT8567142A1 (it) 1986-08-12
JPH0150454B2 (fr) 1989-10-30
JPS60190229A (ja) 1985-09-27
DK65285D0 (da) 1985-02-12
AU3857285A (en) 1985-08-22
DE3504724C2 (de) 1987-03-26
SE8500623L (sv) 1985-08-14
NL8500352A (nl) 1985-09-02
FR2559502A1 (fr) 1985-08-16
DE3504724A1 (de) 1985-09-05
CA1238273A (fr) 1988-06-21
FR2559502B1 (fr) 1988-08-26
NO850535L (no) 1985-08-14
GB2153780B (en) 1987-10-21
GB8503247D0 (en) 1985-03-13
DK65285A (da) 1985-08-14
IT8567142A0 (it) 1985-02-12

Similar Documents

Publication Publication Date Title
BE901704A (fr) Procede d'encapsulation, notamment de cellules, dans des membranes semi-permeables.
AU585377B2 (en) Controlled release pharmaceutical composition
IE40134L (en) Polymeric net
ES8506839A1 (es) Procedimiento para la produccion de velulosa
FR2624125B1 (fr) Composition de polymere/polyol, procede pour sa preparation et son application a la production de polyurethannes
ATE26583T1 (de) Ein latex, biologisch aktive latexkonjugate und verfahren zu ihrer herstellung.
EP0140544A3 (fr) Méthode de préparation de membranes polymères de greffe et membranes d'échanges d'anions et de cations
ATE88731T1 (de) Herstellung von hochmolekularen polytetramethylenadipamid.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
DE3070402D1 (en) Cation exchange resin and production thereof, permselective membrane derived therefrom, and process for producing membrane
GEP19960324B (en) Method for Production of Sulphoadenosyl L _ Methionine Salts
ES8302452A1 (es) "un procedimiento para preparar una capsula farmaceutica que tiene propiedades entericas".
ES8203629A1 (es) Procedimiento para la fabricacion de una membrana para dia- lisis
GR3020156T3 (en) Process for the production of purified glycolipids by the diaphragm separation method
FR2389673A1 (fr)
JPS57119805A (en) Catalytic membrane for hydrolysis
DE3880652D1 (de) Selektive gaspermeationsmembranen und verfahren zu ihrer herstellung.
ATE80178T1 (de) Herstellungsverfahren eines neuen proteolitischen komplexes mit erregender wirkung auf die bauchspeicheldruese, sowie dessen zootechnische verwendungen.
BR9711104B1 (pt) processo para preparar uma composição polidispersada de sacarìdeos, composição polidispersada de sacarìdeos e produto compreendendo uma composição polidispersada de sacarìdeos.
IL83218A0 (en) Manufacturing method for 2-hydroxynaphthalene-6-carboxylic acid
ATE86667T1 (de) Verfahren zur herstellung traegergebundener enzyme.
BR8404193A (pt) Processo industrial para aproducao de poliois,especialmente eritritol e/ou ribitol,pela fermentacao aerobica de um agucar apropriado por moniliella tomentosa var,pollinis,e caldo de cultura contendo poliol
FR2642664B1 (fr) Procede de fabrication d'un ensemble unitaire de membranes de filtration, moule utilise et produit ainsi obtenu
JPS568691A (en) Method and apparatus for continuous production of l-alanine
DK0868473T3 (da) Fremgangsmåde til fremstilling af et ikke fibrøst materiale

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DAMON BIOTECH INC.

Effective date: 19980228